Stay updated with breaking news from Mo Qatanani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
22.05.2024 - Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental ... Seite 1
Scholar Rock Holding Co. (NASDAQ:SRRK – Get Free Report)’s stock price was up 2.9% on Tuesday . The company traded as high as $13.75 and last traded at $13.72. Approximately 49,355 shares were traded during trading, a decline of 94% from the average daily volume of 776,547 shares. The stock had previously closed at $13.33. […]
Raymond James initiated coverage on shares of Scholar Rock (NASDAQ:SRRK – Free Report) in a research report released on Thursday, Marketbeat reports. The firm issued a strong-buy rating and a $30.00 price target on the stock. Other equities analysts have also issued reports about the stock. Piper Sandler restated an overweight rating and issued a […]
A number of research firms have changed their ratings and price targets for Scholar Rock (NASDAQ: SRRK): 3/28/2024 – Scholar Rock is now covered by analysts at Raymond James. They set a “strong-buy” rating and a $30.00 price target on the stock. 3/26/2024 – Scholar Rock had its “overweight” rating reaffirmed by analysts at Piper […]
A number of research firms have changed their ratings and price targets for Scholar Rock (NASDAQ: SRRK): 3/28/2024 – Scholar Rock is now covered by analysts at Raymond James. They set a “strong-buy” rating and a $30.00 price target on the stock. 3/26/2024 – Scholar Rock had its “overweight” rating reaffirmed by analysts at Piper […]